Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cerebrovascular Diseases(Electronic Edition) ›› 2020, Vol. 14 ›› Issue (01): 21-24. doi: 10.11817/j.issn.1673-9248.2020.01.003

Special Issue:

• Expert Forum • Previous Articles     Next Articles

Dual antiplatelet therapy in secondary ischemic stroke prevention

Bin Peng1,()   

  1. 1. Department of Neurology, Peking Union Medical College Hospital, Beijing 100730, China
  • Received:2019-12-10 Online:2020-02-01 Published:2020-02-01
  • Contact: Bin Peng
  • About author:
    Corresponding author: Peng Bin, Email:

Abstract:

Dual antiplatelet therapy is effective in secondary ischemic stroke prevention. However, increased risk of hemorrhage in some patients was noted. It is necessary to balance the benefit and the risk while combined antiplatelet treatment. Target patients, etiological classifications of stroke, duration of medication, types and amounts of antiplatelet drugs and safety are all important aspects needed to be evaluated.

Key words: Antiplatelet drugs, Stroke, Secondary prevention

京ICP 备07035254号-20
Copyright © Chinese Journal of Cerebrovascular Diseases(Electronic Edition), All Rights Reserved.
Tel: 01082266456, 15611963912, 15611963911 E-mail: zhnxgbzzbysy@163.com
Powered by Beijing Magtech Co. Ltd